Degeneration of retinal ganglion cells in hypoxic responses: hypoxia-inducible factor inhibition, a new therapeutic insight
Open Access
- 28 February 2022
- journal article
- editorial
- Published by Medknow in Neural Regeneration Research
- Vol. 17 (10), 2230-2231
- https://doi.org/10.4103/1673-5374.335801
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- HIF Inhibition Therapy in Ocular DiseasesThe Keio Journal of Medicine, 2022
- Fenofibrate Protects against Retinal Dysfunction in a Murine Model of Common Carotid Artery Occlusion-Induced Ocular IschemiaPharmaceuticals, 2021
- HIF inhibitor topotecan has a neuroprotective effect in a murine retinal ischemia-reperfusion modelPeerJ, 2019
- A Novel HIF Inhibitor Halofuginone Prevents Neurodegeneration in a Murine Model of Retinal Ischemia-ReperfusionInternational Journal of Molecular Sciences, 2019
- The Susceptibility of Retinal Ganglion Cells to Glutamatergic Excitotoxicity Is Type-SpecificFrontiers in Neuroscience, 2019
- The Pathophysiology and Treatment of GlaucomaJAMA, 2014
- Evidence-based management of primary angle closure glaucomaCurrent Opinion in Opthalmology, 2014
- The Cell and Molecular Biology of Glaucoma: Axonopathy and the BrainInvestigative Ophthalmology & Visual Science, 2012
- An Optic Nerve Crush Injury Murine Model to Study Retinal Ganglion Cell SurvivalJournal of Visualized Experiments, 2011
- Rodent models of glaucomaBrain Research Bulletin, 2010